Advanced search×

Genotyping of urogenital Chlamydia trachomatis in Regional New South Wales, Australia.

David D Mossman, Kenneth W KW Beagley, Alan L AL Landay, Mark M Loewenthal, Catriona C Ooi, Peter P Timms, and Michael M Boyle

Sex Transm Dis 35(6):614-6 (2008) PMID 18449071

DOI: 10.1097/OLQ.0b013e31816b1b80
Version: za2963e q8zac q8zb4 q8zcb q8zdf q8zeb q8zf2 q8zg0

Similar articles you may find interesting…

  1. Novel Approaches to Vaginal Delivery and Safety of Microbicides: Biopharmaceuticals, Nanoparticles, and Vaccines
    Kevin J Whaley, Justin Hanes, ... David R Friend

    Antiviral Res (2010) PMID 21109069

    The HIV-1 epidemic remains unchecked despite existing technology; vaccines and microbicides in development may help reverse the epidemic. Reverse transcriptase inhibitors (RTIs) formulated in gels tenofovir (TFV) and IVRs (dapivirine) are under clinical development. While TFV or similar products may...
  2. Patented bioavailability enhancement techniques of silymarin.
    Shamama Javed, Kanchan Kohli, and Mushir Ali

    Recent Pat Drug Deliv Formul 4(2):145-52 (2010) PMID 20156178

  3. Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections.
    Farhan Jalees FJ Ahmad, Mohd Aftab MA Alam, ... Mushir M Ali

    Acta Pharm 58(4):407-19 (2008) PMID 19103575

    An acid buffering bioadhesive vaginal (ABBV) gel was developed for the treatment of mixed vaginal infections. Different bioadhesive polymers were evaluated on the basis of their bioadhesive strength, stability and drug release properties. Bioadhesion and release studies showed that guar gum, xanthan...
    PDF not found